Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Publishes One Patent, Two Patent Applications Related to RNAi: Oct 18, 2007

Premium
Title: RNA Interference Pathway Genes as Tools for Targeted Genetic Interference
 
Number: 7,282,564
 
Filed: Aug. 20, 2003
 
Lead Inventor: Craig Mello, University of Massachusetts Medical School
 
“Genes involved in double-stranded RNA interference are identified and used to investigate the RNAi pathway,” the patent’s abstract states. “The genes and their products are also useful for modulating RNAi pathway activity.”
 

Title: Polynucleotides for Reducing Respiratory Syncytial Virus Gene Expression
 
Number: 20070238676 
 
Filed: Dec. 6, 2004 PCT Filed: Dec. 6, 2004
 
Lead Inventor: Shyam Mohapatra, University of South Florida
 
According to the patent application’s abstract, “this invention pertains to polynucleotides, such as small interfering RNA, useful for reducing the expression of respiratory syncytial virus genes within a subject; and methods for treating a patient suffering from, or at risk of developing, an RSV infection by administering such polynucleotides to the subject.”
 

 
Title: siRNA Targeting Chemokine Receptor 4
 
Number: 20070238868
 
Filed: April 3, 2007
 
Lead Inventor: Anastasia Khvorova, Dharmacon (Thermo Fisher Scientific)
 
“Efficient sequence specific gene silencing is possible through the use of siRNA technology,” the patent application’s abstract states. “By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to CXCR4.”

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.